XML 33 R24.htm IDEA: XBRL DOCUMENT

Subsequent Events	6 Months Ended
Subsequent Events	Jun. 30, 2022
Subsequent Events [Abstract]
Subsequent Events	17. Subsequent Events On July 29, 2022 the Company agreed to pay $ 592,665 to settle all outstanding claims related to disputed invoices on a clinical study that was terminated in 2021. The agreement represents full and final settlement of all claims, rights, and demands that each party or its Affiliates may have, and each party has released and discharged any future actions related to any services performed on the cancelled study. The full settlement amount was recorded as a charge to research and development expense in the three months ended June 30, 2022, and payment was made upon execution of the agreement.